CRABP Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of CRABP monoclonal antibodies for investigating cellular retinoic acid binding proteins. CRABP monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cellular retinoic acid binding proteins play a crucial role in the transport and metabolism of retinoic acid, a derivative of vitamin A that is essential for numerous biological processes, including cell differentiation, growth, and apoptosis. By binding retinoic acid, CRABP regulates its availability and activity within cells, influencing gene expression and developmental pathways. Understanding CRABP function is vital for elucidating its implications in various diseases, including cancer and developmental disorders. CRABP research has revealed significant insights into cellular signaling mechanisms and potential therapeutic targets. Ongoing studies continue to uncover new aspects of CRABP biology and its role in health and disease. Recent advances have highlighted CRABP's importance in tissue development and cellular homeostasis. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of CRABP's role in cellular processes and disease mechanisms.